Various eukaryotic translation initiation factors (eIFs) have been implicated in carcinoma development. Eukaryotic translation initiation factor 3 subunit D (eIF3D) has recently been shown to regulate the growth of several types of human cancer cells. However, the function of eIF3D in acute myeloid leukemia (AML) remains unclear. In this study, we investigated the expression of eIF3D in three AML cell lines and a lymphoblast cell line, and found that eIF3D was expressed in all four leukemia cell lines. To explore the role of eIF3D in AML cell proliferation, lentivirus-mediated RNA interference was applied to knock down the expression of eIF3D in U937 cells. The expression of eIF3D was significantly downregulated in U937 cells after eIF3D knockdown, as confirmed by quantitative real-time PCR (qRT-PCR) and Western blot analysis. Knockdown of eIF3D significantly inhibited proliferation of U937 cells. Furthermore, flow cytometry analysis revealed that eIF3D silencing induced cell cycle arrest at the G2/M phase, ultimately leading to apoptosis. Our results indicate that eIF3D plays a key role in the proliferation of AML cells, and suggest that eIF3D silencing might be a potential therapeutic strategy for leukemia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11010-017-3127-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Perturbations in eIF3 subunit stoichiometry alter expression of ribosomal proteins and key components of the MAPK signaling pathways.
Elife
November 2024
Laboratory of Regulation of Gene Expression, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic.
Protein synthesis plays a major role in homeostasis and when dysregulated leads to various pathologies including cancer. To this end, imbalanced expression of eukaryotic translation initiation factors (eIFs) is not only a consequence but also a driver of neoplastic growth. eIF3 is the largest, multi-subunit translation initiation complex with a modular assembly, where aberrant expression of one subunit generates only partially functional subcomplexes.
View Article and Find Full Text PDFeIF3d specialized translation requires a RACK1-driven eIF3d binding to 43S PIC in proliferating SH-SY5Y neuroblastoma cells.
Cell Signal
January 2025
Department of Ecological and Biological Science (DEB), Università degli Studi Della Tuscia, Viterbo, Italy. Electronic address:
Article Synopsis
- Most mammalian mRNAs have a 5' cap that usually binds to a protein called eIF4E for translation initiation.
- Even when eIF4E is inhibited, mRNAs remain capped, indicating that other mechanisms can facilitate translation.
- This study reveals that the ribosomal protein RACK1 can replace eIF4E by recruiting another protein, eIF3d, when a certain active form of PKCBII is present.
Deciphering EIF3D's Role in Immune Regulation and Malignant Progression: A Pan-Cancer Analysis with a Focus on Colon Adenocarcinoma.
J Inflamm Res
September 2024
Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, People's Republic of China.
Article Synopsis
- - EIF3D is a crucial component of the translation initiation factor complex that plays a significant role in processing certain mRNAs and is linked to colon adenocarcinoma (COAD) and its immune environment, but its specific effects on tumor development were not well-studied prior to this research.
- - The study employed various databases and experimental methods to analyze EIF3D expression and its relationship with cancer cell behavior, ultimately finding that higher levels of EIF3D correlate with poor prognoses and significant immune cell infiltration in COAD and other tumors.
- - Results indicated that knocking down EIF3D inhibited COAD cell growth and movement while affecting pathways tied to cell cycle and DNA replication, suggesting it could serve as a prognostic biomarker
Design, synthesis and biological evaluation of plant-derived miliusol derivatives achieve TNBC profound regression in vivo.
Eur J Med Chem
December 2024
School of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China. Electronic address:
Triple-negative breast cancer has become a major problem in clinical treatment due to its high heterogeneity, and Plant-derived drug discovery has been the focus of attention for novel anti-tumor therapeutics. In this study, Miliusol, a natural product isolated from the rarely reported plant Miliusa tenuistipitata, was identified as the lead compound, and 25 miliusol derivatives were designed and synthesized under antiproliferative activity guidance. The results revealed that ZMF-24 was demonstrated to have potent anti-TNBC proliferation with IC values of 0.
View Article and Find Full Text PDFDevelopment of a diagnostic model based on glycolysis-related genes and immune infiltration in intervertebral disc degeneration.
Heliyon
August 2024
Department of Orthopedics, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032, Taiyuan, China.
Background: The glycolytic pathway and immune response play pivotal roles in the intervertebral disc degeneration (IDD) progression. This study aimed to develop a glycolysis-related diagnostic model and analyze its relationship with the immune response to IDD.
Methods: GSE70362, GSE23130, and GSE15227 datasets were collected and merged from the Gene Expression Omnibus, and differential expression analysis was performed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!